HERON THERAPEUTICS, INC. /DE/ Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Heron Therapeutics, Inc. /De/ Return On Equity for the quarter ending June 30, 2024 was 144 %, a 96.1% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Return On Equity for 2023 was 393 %.
  • Heron Therapeutics, Inc. /De/ annual Return On Equity for 2022 was -1.9K %, a 1092% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Return On Equity for 2021 was -160 %, a 111% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 393 +2.3K Jan 1, 2023 Dec 31, 2023
2022 -1.9K -1.74K -1092% Jan 1, 2022 Dec 31, 2022
2021 -160 -84.1 -111% Jan 1, 2021 Dec 31, 2021
2020 -75.6 -13.8 -22.4% Jan 1, 2020 Dec 31, 2020
2019 -61.7 -6.76 -12.3% Jan 1, 2019 Dec 31, 2019
2018 -55 +176 +76.2% Jan 1, 2018 Dec 31, 2018
2017 -231 +240 +51% Jan 1, 2017 Dec 31, 2017
2016 -471 -387 -464% Jan 1, 2016 Dec 31, 2016
2015 -83.5 +19.3 +18.8% Jan 1, 2015 Dec 31, 2015
2014 -103 +35.7 +25.8% Jan 1, 2014 Dec 31, 2014
2013 -138 -67.8 -95.8% Jan 1, 2013 Dec 31, 2013
2012 -70.7 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.